Biotechnology Get all the latest news from the field of biotechnology and its many applications, including testing, treatment, and pharmaceuticals. This category includes research, clinical, and study results, as well as stories about the newest breakthroughs in the industry. Read stories about upcoming conferences and symposiums, along with releases regarding patents, legal activity, company performance, and market analysis.

Latest

27 Apr, 2017, 20:00 ET Aspyrian announces the presentation of clinical data of its investigational therapy RM-1929 demonstrating anti-cancer response in recurrent Head and Neck Cancer patients who have failed all existing treatment options

Aspyrian Therapeutics, Inc., a biotechnology company developing precision-targeted cancer therapies based on the proprietary Photoimmunotherapy...


27 Apr, 2017, 18:58 ET Bayer Receives FDA Approval for Stivarga® (regorafenib) for the Second-Line Systemic Treatment of Liver Cancer

Bayer announced today that the U.S. Food and Drug Administration (FDA) approved Stivarga® (regorafenib) tablets for the second-line treatment of...


27 Apr, 2017, 17:55 ET CytRx Corporation Announces Proposed Public Offering of Common Stock

CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology today announced a proposed public...


27 Apr, 2017, 17:00 ET CryoLife to Present at Deutsche Bank 42nd Annual Health Care Conference

CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that it will...


27 Apr, 2017, 16:45 ET Mylan to Report First Quarter 2017 Financial Results on May 10, 2017

Mylan N.V. (NASDAQ, TASE: MYL) today announced that it will host a conference call and live webcast, on Wednesday, May 10, 2017, at 10 a.m. EDT, to...


27 Apr, 2017, 16:15 ET SENOMYX ANNOUNCES FIRST QUARTER 2017 FINANCIAL RESULTS

Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor...


27 Apr, 2017, 16:10 ET Regulus to Provide First Quarter 2017 Financial Results on May 4, 2017

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


27 Apr, 2017, 16:06 ET Accuray Names Lionel Hadjadjeba Chief Commercial Officer

Accuray Incorporated (Nasdaq: ARAY) today reported the appointment of Lionel Hadjadjeba as senior vice president, chief commercial officer...


27 Apr, 2017, 16:05 ET PhaseRx to Present Data at the TIDES Conference

PhaseRx, Inc. (NASDAQ: PZRX), a biopharmaceutical company developing mRNA treatments for life-threatening inherited liver diseases in children,...


27 Apr, 2017, 16:00 ET Amgen To Participate In The 2017 World Medical Innovation Forum™ Focused On Cardiovascular Disease

Amgen (NASDAQ:AMGN) today announced plans to participate in the World Medical Innovation Forum™ focused on cardiovascular disease held May 1-3,...


27 Apr, 2017, 14:15 ET Next Generation HCV Therapy Presented at the International Liver Congress™ 2017 by Texas Liver Institute's Dr. Fred Poordad

Dr. Fred Poordad, internationally recognized for his research in the field of liver diseases, presented a retreatment study of patients who have...


27 Apr, 2017, 14:00 ET Shalini Sharp Joins Array BioPharma Board of Directors

Array BioPharma Inc. (NASDAQ: ARRY) today announced that Shalini Sharp, Chief Financial Officer and Executive Vice President of Ultragenyx...


27 Apr, 2017, 13:05 ET Kinexum Appoints Thomas Seoh New CEO

Kinexum, a distinguished resource for research, development and commercialization of life science products, today announces the appointment of...


27 Apr, 2017, 12:35 ET Une entreprise canadienne obtient l'approbation de la FDA pour un nouveau produit d'alimentation animale visant à réduire les émissions mondiales de gaz à effet de serre

La Federal Drug Agency (FDA) des États-Unis accorde à l'entreprise Agrisoma Biosciences Inc., établie au Québec, l'autorisation réglementaire de...


27 Apr, 2017, 12:30 ET SRI International Awarded $4.7 Million in Agreements to Manufacture and Test Vaccine Against Venezuelan Equine Encephalitis

SRI International has been awarded two agreements worth $4.7 million to manufacture and conduct clinical testing on a potential new vaccine against...


27 Apr, 2017, 12:24 ET Kasten Merger and Stock Restructure

Kasten, Inc. (OTC Pink: KAST) has completed its acquisition through the merger of DAKOTA Life Sciences, now a wholly owned subsidiary of Kasten,...


27 Apr, 2017, 12:15 ET Scientists at Shriners Hospitals for Children re-wire cells to produce arthritis vaccine

Using a new gene-editing technology, researchers at Shriners Hospitals for Children®— St. Louis and Washington University School of Medicine have...


27 Apr, 2017, 12:13 ET First FDA-Approved 100 mg Thiotepa Now Available through Amneal Biosciences as TEPADINA® (thiotepa) for Injection

Thiotepa is now available through Amneal Biosciences in both 100 mg/vial and 15 mg/vial as branded TEPADINA® (thiotepa) for injection. The product...


27 Apr, 2017, 11:00 ET Chromatography Resin Market Worth 2.46 Billion USD by 2021

The report "Chromatography Resin Market by Type (Natural, Synthetic, Inorganic media), Technique (Ion Exchange, Affinity, Hydrophobic...


27 Apr, 2017, 10:33 ET Pendant Biosciences Announces Acceptance into JLABS @ Toronto

Pendant Biosciences, Inc. (formerly Nanoferix, Inc.), a privately-held advanced materials company developing innovative surface modification and...


27 Apr, 2017, 10:03 ET The most trusted hair restoration brand launches next generation transplant device

In collaboration with top plastic surgeons and dermatologists, NeoGraft® has combined next generation surgical techniques with decades of data....


27 Apr, 2017, 10:00 ET SQI Diagnostics to Present at Bloom Burton Healthcare Investor Conference

TORONTO, April 27, 2017 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; OTCQX: SQIDF), a life sciences and diagnostics...


27 Apr, 2017, 09:50 ET XTL Biopharmaceuticals Appoints Mr. Alex Rabinovich to its Board of Directors

XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTLB.TA) ("XTL" or the "Company"), a clinical-stage biopharmaceutical company developing...


27 Apr, 2017, 09:12 ET Lancement de Smebiocta® en avril 2017, le premier complément alimentaire d'Ipsen en France

- IPSEN en France se renforce dans le domaine de la gastro-entérologie et s'oriente vers un modèle commercial OTx[a] - SMEBIOCTA®...


27 Apr, 2017, 09:08 ET Ipsen en France renforce son engagement dans le domaine de la gastro-entérologie et oriente son modèle commercial vers l'OTx[a]

- Ipsen s'engage dans un nouveau domaine, le microbiote - Lorsque le microbiote est altéré, il s'agit d'une dysbiose Les...